Skip to main content

Year: 2020

IBA Business Update – Third Quarter 2020

Louvain-la-Neuve, Belgium, 19 November 2020 – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update for the third quarter ending 30 September 2020.Olivier Legrain, Chief Executive Officer of IBA SA, commented: “Whilst the global operating environment continues to be impacted by the COVID-19 crisis, IBA’s business is demonstrating encouraging resilience and is well positioned to weather ongoing disruption caused by the pandemic. This resilience is particularly evident in the strengthening of recurring revenues from strong performances of Dosimetry and Services. Other Accelerators also continues to perform very well and as IBA continues to demonstrate its market superiority, we are seeing market share gains in these businesses...

Continue reading

IBA DÉCLARATION INTERMÉDIAIRE TROISIÈME TRIMESTRE 2020 

Louvain-la-Neuve, Belgique, le 19 novembre 2020 – IBA (Ion Beam Applications S.A., EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie aujourd’hui une revue de ses activités au 30 septembre 2020.Olivier Legrain, Chief Executive Office d’IBA, commente : « Alors que l’environnement de nos activités dans le monde continue d’être affecté par la crise COVID-19, les activités d’IBA ont montré une résilience encourageante et sont bien positionnées pour surmonter les perturbations causées par la pandémie. Cette résilience est particulièrement flagrante dans le renforcement des revenus récurrents, des bonnes performances de Dosimétrie et des Services. La division Autres Accélérateurs continue également de réaliser de très bons résultats et, alors qu’IBA poursuit la démonstration de...

Continue reading

Nokia launches world’s first 25 Gbps symmetrical PON solution

Press ReleaseNokia launches world’s first 25 Gbps symmetrical PON solution25G PON technology is the next step in PON (passive optical network) evolution and enables the converging of high-end services on a single fiber infrastructureNokia’s 25G PON solution will be available on the widely deployed Nokia fibre access platform, enabling a smooth introductionBased on the Nokia Quillion chipset, the 25G PON solution provides the high capacity and low latency needed for 5G transport and premium enterprise services              19 November, 2020Espoo, Finland – Nokia has today announced the world’s first 25 Gbps symmetrical PON fiber broadband solution. This unique solution works on Nokia’s existing next-generation PON hardware, such as access nodes and line cards, to offer truly universal PON capabilities and enable communications service...

Continue reading

Planned changes in the Management of LHV Pank

AS LHV Group intends to appoint Erki Kilu as the Head of a subsidiary to be established in the United Kingdom, i.e. a new bank. In this regard, the Supervisory Board of AS LHV Pank plans to elect Kadri Kiisel as the new Chairman of the Management Board of AS LHV Pank. According to the plans, the changes in the Management of the company will take effect on 20 January 2021.Pursuant to the stock exchange announcement of 23 October, LHV is more clearly separating the business operations of LHV Pank in the United Kingdom and the business in Estonia, and is going to set up a new credit institution for providing services to its clients who are international payment intermediaries. The establishment of a subsidiary is currently in process, followed by manning, capitalisation and application for the activity licence of the credit institution.According...

Continue reading

Shareholder Update

TAMPA, FL, Nov. 19, 2020 (GLOBE NEWSWIRE) —  via NewMediaWire — REMSleep Holdings, Inc. (OTC PINK: RMSL) Gives an update on FDA process. We have had numerous inquiries regarding REMSleep regulatory status.  The new Deltawave nasal pillows mask evolved from the company’s original 510K and CPAP mask, Laminair. For an extended period, it was the company’s understanding the new Deltawave CPAP interface would be covered under our original “Laminair” 510K with a name change and notifications of insignificant material/design changes and features represented in our original 510K. After repeated reviews from the company’s FDA consultants the company was informed the improvements to the Deltawave were too extensive, superimposed with recently added regulations, which would require filing a new 510K. The...

Continue reading

African Gold Group Increases Vertical Depth of Oxide Ore Body, Intersects 18.5 g/t Au and 8.41 g/t Au at the Kobada Gold Project on In-Fill Drilling Programme

African Gold Group would like to invite shareholders and the general public to join AGG management team for a live webinar to discuss ongoing drilling program.The investor webinar will take place on Wednesday, November 25that 10:00 am (EST). Online registration and participation details may be found at the following link:https://zoom.us/webinar/register/WN_o-Lo3uHcRd2Y2YCqekJ6BATORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) is pleased to announce updated results from its Phase 4 in-fill drilling campaign targeting conversion of Inferred oxides into Measured and Indicated Resources. Most recent drilling results continue to show extensions of the oxide orebody at depth, far deeper than expected with numerous high-grade gold intersections. Ongoing drilling continues to test...

Continue reading

Berkeley Lights Announces Pricing of Public Offering by Selling Stockholders

EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) — Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares of common stock to be sold by certain selling stockholders of Berkeley Lights at a public offering price of $86.00 per share. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock. The offering is expected to close on or about November 23, 2020, subject to the satisfaction of customary closing conditions. The selling stockholders will receive all of the net proceeds from the offering. Berkeley Lights will not receive any proceeds from the offering.J.P. Morgan, Morgan Stanley and Cowen are acting as lead book-running managers for the offering.A...

Continue reading

Playa Hotels & Resorts N.V. Announces Pricing of Upsized Secondary Offering of 13,575,739 Ordinary Shares by Selling Shareholders

FAIRFAX, Va., Nov. 18, 2020 (GLOBE NEWSWIRE) — Playa Hotels & Resorts N.V. (NASDAQ: PLYA) (“Playa”) today announced the pricing of an upsized underwritten secondary offering of 13,575,739 of its Ordinary Shares by certain selling shareholders (the “Selling Shareholders”) affiliated with Farallon Capital Management, L.L.C. (collectively, the “Farallon Funds”), at a public offering price of $4.10 per Ordinary Share, which is expected to result in gross proceeds to the Selling Shareholders of approximately $55.7 million (assuming no exercise of the underwriter’s option to purchase up to 2,036,361 additional Ordinary Shares). The offering was upsized from the previously announced 12,500,000 Ordinary Shares. The offering is expected to close on November 23, 2020, subject to customary closing conditions. Upon consummation of the...

Continue reading

Supernus to Participate in Annual Piper Sandler Healthcare Conference

ROCKVILLE, Md., Nov. 18, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will participate in a fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held December 1-3, 2020. The Company will also host investor meetings on Thursday, December 3, 2020.The pre-recorded fireside chat can be accessed beginning November 23, 2020 by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of this fireside chat will be available for 60 days on the Company’s website after the conference.About Supernus Pharmaceuticals, Inc.Supernus...

Continue reading

Jamf Announces Upsize and Pricing of Follow-on Offering of Common Stock by Selling Shareholders

MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) — Jamf Holding Corp. (“Jamf”) (NASDAQ: JAMF), the standard in Apple Enterprise Management, today announced the pricing of a public follow-on offering of 11,000,000 shares of its common stock by certain selling shareholders at $32.00 per share. The offering was upsized from the previously announced offering size of 10,000,000 shares. Certain of the selling shareholders also granted the underwriters a 30-day option to purchase up to an additional 1,650,000 shares on the same terms and conditions. The offering is expected to close on November 23, 2020, subject to customary closing conditions.Jamf will not receive any proceeds from the sale of shares by the selling shareholders, and will not issue any shares of its common stock in the offering.Goldman Sachs & Co. LLC, J.P. Morgan, BofA...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.